Clinical Trial Supply USA: Investment & Opportunity

Add bookmark

We respect your privacy, by clicking "Download Your Copy" you agree to having your details passed onto the sponsor who may promote similar products and services related to your area of interest subject to their privacy policy. You have the right to object. In addition, you will receive our e-newsletter, including information on related online learning opportunities. For further information on how we process and monitor your personal data, and information about your privacy and opt-out rights, click here.

Clinical development continues to be the most expensive, time consuming aspect of getting a drug to market and ensuring the safe, accurate supply of clinical trial products to project sites provides yet more challenges to overcome in the process.

This infographic from our sister site Pharma IQ reveals the latest thinking on clinical trial supply and where it is going. Nearly a third of all respondents stated that CROs would be an area of active investment in the next 6 months. 50% of respondents will be running 6 or more clinical trials in the BRIC region. Find out more today!